Expression library immunization to discover and improve vaccine antigens

Immunological Reviews
M A BarryRana A K Singh

Abstract

Genetic immunization is a novel method for vaccination in which DNA is delivered into the host to drive both cellular and humoral immune responses against its protein product. While genetic immunization can be potent, it requires that one have, in hand, a gene that encodes a protective protein antigen. Therefore, for many diseases, one cannot make a genetic vaccine because no protective antigen is known or no gene for this antigen is available. This lack of candidate antigens and their genes is a considerable bottleneck in developing new vaccines against old infectious agents, new emerging pathogens, and bioweapons. To address this limitation, we developed expression library immunization (ELI) as a high-throughput technology to discover vaccine candidate genes at will, by using the immune system to screen the entire genome of a pathogen for vaccine candidate. To date, ELI has discovered new vaccine candidates from a diverse set of bacterial, fungal, and parasitic pathogens. In addition, the process of applying ELI to the genome of pathogens allows one to genetically re-engineer these antigens to convert immunoevasive pathogen proteins into immunostimulatory vaccine antigens. Therefore, ELI is a potent technology to discover new...Continue Reading

References

Sep 1, 1992·Human Molecular Genetics·J A WolffA Jani
Mar 23, 1990·Science·J A WolffP L Felgner
Dec 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·N S YangD McCabe
Jul 21, 1995·The Journal of Biological Chemistry·E S JohnsonA Varshavsky
Dec 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·E F FynanH L Robinson
Dec 5, 1995·Proceedings of the National Academy of Sciences of the United States of America·T C WuD M Pardoll
May 1, 1996·Trends in Microbiology·J B Ulmer, M A Liu
Jul 8, 1997·Proceedings of the National Academy of Sciences of the United States of America·J van BergenF Koning
Jun 1, 1997·Vaccine·S A Johnston, M A Barry
Jul 21, 1998·Annals of the New York Academy of Sciences·K A BraytonB A Allsopp
Aug 11, 1998·Immunology Letters·K ManoutcharianT Govezensky
Nov 25, 1998·Proceedings of the National Academy of Sciences of the United States of America·S C Jameson
Dec 10, 1998·Nature Medicine·S L HoffmanJ C Venter
Apr 20, 1999·Nature Biotechnology·K F Sykes, S A Johnston
Aug 5, 1999·DNA and Cell Biology·K F Sykes, S A Johnston
Nov 2, 1999·The EMBO Journal·T Suzuki, A Varshavsky
Mar 21, 2000·Nature·I Schubert, U Wobus
Sep 14, 2000·Molecular Therapy : the Journal of the American Society of Gene Therapy·L Wu, M A Barry

❮ Previous
Next ❯

Citations

Oct 22, 2005·Infection and Immunity·Adel M Talaat, Katherine Stemke-Hale
May 4, 2007·The Journal of Clinical Investigation·Eli Gilboa
Feb 16, 2016·Vaccine·Jitendra Singh Rathore, Yan Wang
Mar 29, 2008·Veterinary Microbiology·Abdolreza Reza Movahedi, David J Hampson
Feb 12, 2009·Proteomics·Carla Herrera-NajeraEric Dumonteil
Jun 29, 2013·Vaccine·Daniel GrubaughDarren E Higgins
Jun 1, 2007·FEMS Immunology and Medical Microbiology·Daniel YeroArmando Acosta
Feb 3, 2015·Current Protocols in Microbiology·Peter Michael Moyle
Mar 23, 2021·World Journal of Microbiology & Biotechnology·Abhinay SharmaAtul Kumar Johri

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.